Biomarkers for Monitoring ALS Progression
Study Description
“Novel MRI Biomarkers for Monitoring Disease Progression in ALS”
Routine MRI is normal in motor neuron diseases such as ALS. However, advanced MRI techniques can provide an objective measure of degeneration (a "biomarker") by examining brain structure, wiring, chemistry, and function. We will develop and evaluate novel MRI techniques that could improve our understanding of ALS and provide a means to diagnose it sooner and monitor its progression. Importantly, we expect these techniques to improve how new drugs are tested, which may lead to the more rapid discovery of a treatment for ALS. Each participant will have 3 MRI scans over a period of 8 months, along with neurological and cognitive evaluations. Study visits will take 2 - 3 hours. MRI is a safe technique that does not involve radiation.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Additional Information
Official Study Title
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Clinical Trial ID
NCT03362658
ParticipAid ID
mbkmYe
